Companies / Fate Therapeutics Inc / Activity
Activity — Fate Therapeutics Inc
65 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | Exit | Common stock | $-292.9K | -298K -100.00% | 0 | low |
| Q1 2021 as of | Leonteq Securities AG 13F manager | Trim | Common stock | $-295.4K | -4K -89.96% | 400 <0.01% of shares | low |
| Q3 2025 as of | Barclays PLC 13F manager | Trim | Common stock | $-305.7K | -243K -53.54% | 210,487 0.18% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Exit | Common stock | $-513.5K | -523K -100.00% | 0 | low |
| Q2 2024 as of | Barclays PLC 13F manager | Trim | Common stock | $-660.4K | -201K -62.10% | 122,888 0.10% of shares | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | Add | Common stock | $736.6K | +614K +26.00% | 2,974,683 2.48% of shares | low |
| Q3 2023 as of | Barclays PLC 13F manager | Trim | Common stock | $-763.9K | -360K -75.21% | 118,751 0.10% of shares | low |
| Q2 2026 as of | Monaco Asset Management SAM 13F manager | Exit | Common stock | $-815.6K | -830K -100.00% | 0 | low |
| Q4 2023 as of | Barclays PLC 13F manager | Add | Common stock | $899.9K | +241K +202.63% | 359,375 0.30% of shares | low |
| Q3 2024 as of | Barclays PLC 13F manager | Add | Common stock | $1.05M | +301K +245.26% | 424,277 0.35% of shares | low |
| Q1 2023 as of | Barclays PLC 13F manager | Add | Common stock | $1.35M | +237K +89.80% | 500,822 0.42% of shares | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | Common stock | $2.08M | +1.7M +99.92% | 3,466,786 2.89% of shares | low |
| Q1 2026 as of | AQR Capital Management, LLC 13F manager | Add | Common stock | $2.21M | +1.8M +158.31% | 3,001,521 2.51% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | Trim | Common stock | $-4.61M | -1.7M -75.33% | 558,928 0.47% of shares | low |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Trim | Common stock | $-7.77M | -2.9M -28.28% | 7,298,895 6.09% of shares | medium |